New hubs receive over £32m to improve access to vaccines in LMICs
Communicable diseases account for 50% of all deaths in LMICs
Read More
Tag: UK Vaccine Network
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
